News Releases Keyword Search Year None20242023202220212020201920182017201620152014 04/02/24 Vaccinex Reports 2023 Financial Results and Provides Corporate Update 03/27/24 Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules 02/21/24 Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology 02/15/24 Vaccinex, Inc. Announces Reverse Stock Split 02/07/24 Vaccinex Announces Pricing of $3.7 Million PIPE Financing
03/27/24 Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules